Furthermore, Jobe et al. demonstrated that IL-6 and IL-8, which are upregulated in sera of melanoma patients and correlate with their overall survival, are promising molecular targets to inhibit melanoma cell invasion successfully [139,140]. The gene discussed is IL6; the disease is melanoma.